The protein type within a hypocaloric diet affects obesity-related inflammation: The RESMENA project

Nutrition

Volumn 30, Issue 4, 2014, Pages 424-429

  Lopez Legarrea, Patricia ^a   de la Iglesia, Rocio ^a   Abete, Itziar ^b,c   Navas Carretero, Santiago ^a,c   Martinez, J Alfredo ^a,c   Zulet, M Angeles ^a,c  

^a UNIVERSITY OF NAVARRA   (Spain)

^b BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cardiovascular diseases; Inflammation markers; Macronutrient distribution; Metabolic syndrome; Weight loss

Indexed keywords

C REACTIVE PROTEIN; FISH PROTEIN; INTERLEUKIN 6; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR ALPHA; VEGETABLE PROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; HUMAN; INFLAMMATION; LOW CALORY DIET; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MOLECULAR DYNAMICS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; TREATMENT RESPONSE; WEIGHT REDUCTION;

CARDIOVASCULAR DISEASES; INFLAMMATION MARKERS; MACRONUTRIENT DISTRIBUTION; METABOLIC SYNDROME; WEIGHT LOSS;

ADULT; ANIMALS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALORIC RESTRICTION; DIET, REDUCING; DIETARY PROTEINS; FEMALE; FISH PROTEINS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MEAT; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; TUMOR NECROSIS FACTOR-ALPHA; VEGETABLE PROTEINS; WEIGHT LOSS;

EID: 84895489456     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2013.09.009     Document Type: Article

References (42)

1. Clark M.L., Butler L.M., Koh W.P., Wang R., Yuan J.M. Dietary fiber intake modifies the association between secondhand smoke exposure and coronary heart disease mortality among Chinese non-smokers in Singapore. Nutrition 2013, 29:1304-1309.
2. Abete I., Goyenechea E., Zulet M.A., Martinez J.A. Obesity and metabolic syndrome: potential benefit from specific nutritional components. Nutr Metab Cardiovasc Dis 2011, 21(suppl 2):B1-B15.
3. Bondia-Pons I., Ryan L., Martinez J.A. Oxidative stress and inflammation interactions in human obesity. J Physiol Biochem 2012, 68:701-711.
4. Wijnstok N.J., Twisk J.W., Young I.S., Woodside J.V., McFarlane C., McEneny J., et al. Inflammation markers are associated with cardiovascular diseases risk in adolescents: the Young Hearts project 2000. J Adolesc Health 2010, 47:346-351.
5. Golan R., Tirosh A., Schwarzfuchs D., Harman-Boehm I., Thiery J., Fiedler G.M., et al. Dietary intervention induces flow of changes within biomarkers of lipids, inflammation, liver enzymes, and glycemic control. Nutrition 2012, 28:131-137.
6. Asemi Z., Samimi M., Tabassi Z., Sabihi S.S., Esmaillzadeh A. A randomized controlled clinical trial investigating the effect of DASH diet on insulin resistance, inflammation, and oxidative stress in gestational diabetes. Nutrition 2013, 29:619-624.
7. Richard C., Couture P., Desroches S., Lamarche B. Effect of the Mediterranean diet with and without weight loss on markers of inflammation in men with metabolic syndrome. Obesity (Silver Spring) 2013, 21:51-57.
8. DeBoer M.D. Obesity, systemic inflammation, and increased risk for cardiovascular disease and diabetes among adolescents: a need for screening tools to target interventions. Nutrition 2013, 29:379-386.
9. Belalcazar L.M., Ballantyne C.M., Lang W., Haffner S.M., Rushing J., Schwenke D.C., et al. Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD study. Arterioscler Thromb Vasc Biol 2011, 31:1689-1695.
10. de Mello V.D., Schwab U., Kolehmainen M., Koenig W., Siloaho M., Poutanen K., et al. A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study. Diabetologia 2011, 54:2755-2767.
11. Hermsdorff H.H., Zulet M.A., Puchau B., Bressan J., Martinez J.A. Association of retinol-binding protein-4 with dietary selenium intake and other lifestyle features in young healthy women. Nutrition 2009, 25:392-399.
12. Lopez-Legarrea P., de la Iglesia R., Abete I., Bondia-Pons I., Navas-Carretero S., Forga L., et al. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: the RESMENA randomized controlled trial. Nutr Metab (Lond) 2013, 10:22.
13. Gogebakan O., Kohl A., Osterhoff M.A., van Baak M.A., Jebb S.A., Papadaki A., et al. Effects of weight loss and long-term weight maintenance with diets varying in protein and glycemic index on cardiovascular risk factors: the diet, obesity, and genes (DiOGenes) study: a randomized, controlled trial. Circulation 2011, 124:2829-2838.
14. Salehi-Abargouei A., Maghsoudi Z., Shirani F., Azadbakht L. Effects of dietary approaches to stop hypertension (DASH)-style diet on fatal or nonfatal cardiovascular diseases-incidence: a systematic review and meta-analysis on observational prospective studies. Nutrition 2013, 29:611-618.
15. Bhupathiraju S.N., Lichtenstein A.H., Dawson-Hughes B., Tucker K.L. Adherence index based on the AHA 2006 diet and lifestyle recommendations is associated with select cardiovascular disease risk factors in older Puerto Ricans. J Nutr 2011, 141:460-469.
16. Westerterp-Plantenga M.S., Lemmens S.G., Westerterp K.R. Dietary protein - its role in satiety, energetics, weight loss and health. Br J Nutr 2012, 108(suppl 2):S105-S112.
17. Santesso N., Akl E.A., Bianchi M., Mente A., Mustafa R., Heels-Ansdell D., et al. Effects of higher- versus lower-protein diets on health outcomes: a systematic review and meta-analysis. Eur J Clin Nutr 2012, 66:780-788.
18. Hermsdorff H.H., Zulet M.A., Abete I., Martinez J.A. A legume-based hypocaloric diet reduces proinflammatory status and improves metabolic features in overweight/obese subjects. Eur J Nutr 2011, 50:61-69.
19. Azadbakht L., Esmaillzadeh A. Red meat intake is associated with metabolic syndrome and the plasma C-reactive protein concentration in women. J Nutr 2009, 139:335-339.
20. Alberti K.G., Zimmet P., Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005, 366:1059-1062.
21. Turner L., Shamseer L., Altman D.G., Weeks L., Peters J., Kober T., et al. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals. Cochrane Database Syst Rev 2012, 11:MR000030.
22. de la Iglesia R., Lopez-Legarrea P., Abete I., Bondia-Pons I., Navas-Carretero S., Forga L., et al. A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project. Br J Nutr 2013;23, 1-10.
23. Zulet M.A., Bondia-Pons I., Abete I., de la Iglesia R., Lopez-Legarrea P., Forga L., et al. The reduction of the metabolyc syndrome in Navarra-Spain (RESMENA-S) study: a multidisciplinary strategy based on chrononutrition and nutritional education, together with dietetic and psychological control. Nutr Hosp 2011, 26:16-26.
24. Jebb S.A., Ahern A.L., Olson A.D., Aston L.M., Holzapfel C., Stoll J., et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011, 378:1485-1492.
25. Clifton P.M., Bastiaans K., Keogh J.B. High protein diets decrease total and abdominal fat and improve CVD risk profile in overweight and obese men and women with elevated triacylglycerol. Nutr Metab Cardiovasc Dis 2009, 19:548-554.
26. Kolb H., Mandrup-Poulsen T. The global diabetes epidemic as a consequence of lifestyle-induced low-grade inflammation. Diabetologia 2010, 53:10-20.
27. Clement K., Viguerie N., Poitou C., Carette C., Pelloux V., Curat C.A., et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004, 18:1657-1669.
28. Guebre-Egziabher F., Debard C., Drai J., Denis L., Pesenti S., Bienvenu J., et al. Differential dose effect of fish oil on inflammation and adipose tissue gene expression in chronic kidney disease patients. Nutrition 2013, 29:730-736.
29. Wycherley T.P., Moran L.J., Clifton P.M., Noakes M., Brinkworth G.D. Effects of energy-restricted high-protein, low-fat compared with standard-protein, low-fat diets: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012, 96:1281-1298.
30. Larsen T.M., Dalskov S.M., van Baak M., Jebb S.A., Papadaki A., Pfeiffer A.F., et al. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010, 363:2102-2113.
31. Azadbakht L., Kimiagar M., Mehrabi Y., Esmaillzadeh A., Hu F.B., Willett W.C. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. Br J Nutr 2007, 98:807-813.
32. Montonen J., Boeing H., Fritsche A., Schleicher E., Joost H.G., Schulze M.B., et al. Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress. Eur J Nutr 2012, 52:337-345.
33. Baumgartner S., Kelly E.R., van der Made S., Berendschot T.T., Husche C., Lutjohann D., et al. The influence of consuming an egg or an egg-yolk buttermilk drink for 12 wk on serum lipids, inflammation, and liver function markers in human volunteers. Nutrition 2013, 29:1237-1244.
34. Azadbakht L., Kimiagar M., Mehrabi Y., Esmaillzadeh A., Hu F.B., Willett W.C. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care 2007, 30:967-973.
35. Uribarri J., Woodruff S., Goodman S., Cai W., Chen X., Pyzik R., et al. Advanced glycation end products in foods and a practical guide to their reduction in the diet. J Am Diet Assoc 2010, 110:911. e12-916. e12.
36. Uribarri J., Cai W., Sandu O., Peppa M., Goldberg T., Vlassara H. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci 2005, 1043:461-466.
37. Vlassara H., Cai W., Crandall J., Goldberg T., Oberstein R., Dardaine V., et al. Inflammatory mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 2002, 99:15596-15601.
38. Peppa M., Goldberg T., Cai W., Rayfield E., Vlassara H. Glycotoxins: a missing link in the "relationship of dietary fat and meat intake in relation to risk of type 2 diabetes in men". Diabetes Care 2002, 25:1898-1899.
39. Fernandez-Real J.M., Lopez-Bermejo A., Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes 2002, 51:2348-2354.
40. Benatar J.R., Gladding P., White H.D., Zeng I., Stewart R.A. Trans-fatty acids in New Zealand patients with coronary artery disease. Eur J Cardiovasc Prev Rehabil 2011, 18:615-620.
41. Santos S., Oliveira A., Casal S., Lopes C. Saturated fatty acids intake in relation to C-reactive protein, adiponectin, and leptin: a population-based study. Nutrition 2013, 29:892-897.
42. Murphy K.J., Thomson R.L., Coates A.M., Buckley J.D., Howe P.R. Effects of eating fresh lean pork on cardiometabolic health parameters. Nutrients 2012, 4:711-723.